To get close to profitability, Price is also betting on Neutralase, a drug that would be used in coronary-artery bypass graft operations--more commonly referred to as open-heart surgery.

FORBES: BioMarin Gets Ready To Bloom

The participants in Dr Bolli's study were 23 unfortunates who had each had at least one heart attack in the past, and were thus lined up for coronary-bypass surgery, in which the furred-up blood supply to the heart is replaced with an alternative artery crafted from a blood vessel taken from elsewhere usually the leg.

ECONOMIST: Stem cells and medicine: Repairing broken hearts | The